Since 2004, BCHT has built a robust R&D and quality control system, launched three vaccines (Varicella, Herpes Zoster, Influenza), and established a step-wise pipeline of over 10 vaccines and monoclonal antibodies. Its 225,700㎡ manufacturing base reflects a strong commitment to preventing and treating infectious diseases.
Country/Region
CHINA
Products & Services
Biopharmaceuticals (general category)ImmunologyInjectablesMonoclonal AntibodiesOut-licensingPowdersSpraysTech transfer and Scale up
